RECBIO-B released its interim results, with a loss attributable to shareholders of 341 million yuan, an increase of 36.7% year-on-year
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, RECBIO-B released its mid-term performance for 2025, with revenue from continuing operations of RMB 10.899 million, compared to none in the same period last year; the loss attributable to the parent company’s owners was RMB 341 million, an increase of 36.7% year-on-year; basic loss per share was RMB 0.71. The year-on-year increase in revenue was mainly due to income generated from the granting of intellectual property licenses during the period
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments